Biologic Options for Glenohumeral Arthritis

Benjamin Y Jong; Danny P Goel

doi:10.1016/j.csm.2018.06.001

Biologic Options for Glenohumeral Arthritis

Clin Sports Med. 2018 Oct;37(4):537-548. doi: 10.1016/j.csm.2018.06.001. Epub 2018 Aug 3.

Authors

Benjamin Y Jong¹, Danny P Goel²

Affiliations

¹ Department of Orthopaedics, University of British Columbia, 3114-910 West 10th Avenue, Vancouver, British Columbia V5Z 1M9, Canada.
² Department of Orthopaedics, University of British Columbia, Vancouver, Canada. Electronic address: danny.goel@ubc.ca.

PMID: 30201168
DOI: 10.1016/j.csm.2018.06.001

Abstract

Biologic options for glenohumeral arthritis include intra-articular injections as well as allograft interposition arthroplasty. The objectives of these treatments are reduction of pain and maintenance/improvement in function, while delaying the need for arthroplasty. This article reviews the current evidence for hyaluronic acid injection, platelet-rich plasma injection, and allograft interposition arthroplasty in the young patient with glenohumeral arthritis.

Keywords: Allograft; Biologic; Glenohumeral arthritis; Injections; Interposition.

Publication types

Review

MeSH terms

Arthritis / therapy*
Biological Products / therapeutic use*
Humans
Injections, Intra-Articular
Platelet-Rich Plasma
Shoulder Joint / physiopathology*
Transplantation, Homologous

Substances

Biological Products